Quantcast
Don’t Miss This Trade in uniQure NV (QURE) | The Mesh Report

Don’t Miss This Trade in uniQure NV (QURE)

Christian Tharp, CMT September 9, 2020 Comments Off on Don’t Miss This Trade in uniQure NV (QURE)

A key support level has formed in the chart of uniQure NV (QURE – Get Rating).  A trade below this level could cause a breakdown in the stock.

QURE is a gene therapy company. It develops treatment for patients suffering from genetic and other devastating diseases.

The company just started clinical trials of a gene therapy for Huntington’s disease. If the gene therapy succeeds, it could mean a $7 billion annual market for QURE.

See chart and continue reading at STOCKNEWS.com



Comments are closed.